Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 12 Carcinoma, Hepatocellular 11 Carcinoma, Non-Small-Cell Lung 9 Nasopharyngeal Carcinoma 8 Esophageal Squamous Cell Carcinoma 8 Stomach Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Small Cell Lung Carcinoma 4 Liver Neoplasms 4 Carcinoma, Transitional Cell 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Hypopharyngeal Neoplasms 3 Cholangiocarcinoma 3 Solid Tumor 2 Recurrence 2 Lymphoma 2 Laryngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Upper Tract Urinary Carcinoma 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × PD-1 × toripalimab × Clear all

NCT04061928 2019-08-20

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Peking University

Phase 1/2 Unknown

Gastrointestinal

PD-1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡